tiprankstipranks
Trending News
More News >
ImmunityBio (DE:26CA)
FRANKFURT:26CA
Germany Market

ImmunityBio (26CA) Cash flow

Compare
15 Followers

ImmunityBio Cash Flow

DE:26CA's free cash flow for Q4 2025 was $-71.25M. For the 2025 fiscal year, DE:26CA's free cash flow was decreased by $89.34M and operating cash flow was $-70.38M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -304.94M$ -391.24M$ -366.76M$ -337.51M$ -274.42M
Investing Cash Flow
$ -149.80M$ -12.25M$ -30.47M$ 27.30M$ -84.89M
Financing Cash Flow
$ 400.24M$ 281.63M$ 558.34M$ 233.61M$ 505.44M
End Cash Position
$ 89.43M$ 143.91M$ 265.79M$ 104.97M$ 181.28M
Free Cash Flow
$ -308.78M$ -398.12M$ -397.34M$ -415.67M$ -307.98M
Currency in USD

ImmunityBio Cash Flow